Novartis announced a restructuring plan yesterday which involves cutting between 400 - 440 development jobs in Switzerland over the next few years.
Another 240 jobs are at risk in the USA.
The Basel-based pharmaceutical company currently employs over 10’000 people, around 3’000 of whom are dedicated to development.
The company, which is consistently ranked as one of the global top 5 pharmaceutical companies in the world, insists that its research activities will remain unaffected.
French/Swiss crime network smashed
A major cross-border criminal network targeting Switzerland has been dismantled following a joint investigation by French and Swiss authorities.
Zurich commuters face transport upheaval
More than 800,000 people rely on Zurich’s public transport every day, and from today, many of them will be navigating unfamiliar routes.
Small relaxation for cross-border school students
The debate over cross-border students in Geneva schools took another turn in the Grand Council.
SSR SRG may return to FM
Switzerland’s transition to DAB radio is hitting some significant hurdles.
Geneva law on right-to-buy faces vote
In Geneva, a long-standing restriction on tenants buying the apartments they live in has been significantly loosened.
Geneva SPA under investigation
Geneva’s Cantonal Service for Consumer and Veterinary Affairs has opened an investigation into the Geneva Society for the Protection of Animals following complaints from former employees.
